| Literature DB >> 28823823 |
Shuuichi Mori1, Norio Motohashi1, Rumi Takashima1, Masahiko Kishi2, Hiroshi Nishimune3, Kazuhiro Shigemoto4.
Abstract
Since the first report of experimental animal models of myasthenia gravis (MG) with autoantibodies against low-density lipoprotein receptor-related protein 4 (LRP4), there have not been any major reports replicating the pathogenicity of anti-LRP4 antibodies (Abs). Recent clinical studies have cast doubt on the specificity and pathogenicity of anti-LRP4 antibodies for MG, highlighting the need for further research. In this study, we purified antigens corresponding to the extracellular region of human LRP4 stably expressed with chaperones in 293 cells and used these antigens to immunize female A/J mice. Immunization with LRP4 protein caused mice to develop myasthenia having similar electrophysiological and histological features as are observed in MG patients with circulating Abs against muscle-specific kinase (MuSK). Our results clearly demonstrate that active immunization of mice with LRP4 proteins causes myasthenia similar to the MG induced by anti-MuSK Abs. Further experimental and clinical studies are required to prove the pathogenicity of anti-LRP4 Abs in MG patients.Entities:
Keywords: Animal model; Lrp4; MuSK; Myasthenia gravis; Neuromuscular junction
Mesh:
Substances:
Year: 2017 PMID: 28823823 DOI: 10.1016/j.expneurol.2017.08.006
Source DB: PubMed Journal: Exp Neurol ISSN: 0014-4886 Impact factor: 5.330